Version 5.4
Homo sapiens Protein: DBNDD2
Summary
InnateDB Protein IDBP-77600.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol DBNDD2
Protein Name dysbindin (dystrobrevin binding protein 1) domain containing 2
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000361805
InnateDB Gene IDBG-402337 (DBNDD2)
Protein Structure
UniProt Annotation
Function May modulate the activity of casein kinase-1. Inhibits CSNK1D autophosphorylation (in vitro). {ECO:0000269PubMed:16618118}.
Subcellular Localization
Disease Associations
Tissue Specificity Detected in brain. {ECO:0000269PubMed:16618118}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 7 experimentally validated interaction(s) in this database.
Experimentally validated
Total 7 [view]
Protein-Protein 7 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
Biological Process
GO:0006469 negative regulation of protein kinase activity
Cellular Component
GO:0005737 cytoplasm
Protein Structure and Domains
PDB ID
InterPro IPR007531 Dysbindin
PFAM PF04440
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q9BQY9
PhosphoSite PhosphoSite-Q9BQY9
TrEMBL
UniProt Splice Variant
Entrez Gene 55861
UniGene
RefSeq NP_060948
HUGO HGNC:15881
OMIM 611453
CCDS CCDS56193
HPRD 12763
IMGT
EMBL AF220191 AJ276469 AK000531 AL021578 AL591565 AY113697 BC001105 BC012818 BG703352 CH471077
GenPept AAF67656 AAH01105 AAH12818 AAM77463 BAA91235 CAB83042 CAC18108 CAC18109 CAC39141 CAI21087 EAW75848 EAW75854

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca